Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05493501 |
|---|---|
| Brief Title: | Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer |
| First Submitted : | June 24, 2022 |
| First Submitted that Met QC Criteria : | August 5, 2022 |
| First Posted : | August 9, 2022 |
| Results First Submitted : | November 1, 2023 |
| Results First Posted with QC Comments : | November 21, 2023 |
| Results First Submitted that Met QC Criteria : | April 9, 2024 |
| Results First Posted : | May 2, 2024 |
| Last Update Submitted that Met QC Criteria : | April 9, 2024 |
| Last Update Posted : | May 2, 2024 |